Skip to main content
Kineta, Inc. (KANT)
OTCMKTS · Delayed Price · Currency is USD
0.3361
+0.0461 (15.90%)
Inactive · Last trade price on Jun 27, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20
Next-generation Immunotherapies
5.44M
Log In
Log In
Log In
Next-generation Immunotherapies Growth
178.65%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20
United States
5.44M
Log In
Log In
Log In
United States Growth
178.65%
Log In
Log In
Log In